Physician profile
Charles Allen Joyner
NPI 1609897206
$84,514.58
in general payments reported to CMS, 2019-2025
34 companies · $5,022 in 2025
The $5,022 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $6,316 · 2021: $9,630 · 2022: $13K · 2023: $6,514 · 2024: $3,146 · 2025: $5,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,914 · Consulting Fee: $4,125 · Travel and Lodging: $3,343 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,914.13 |
| Consulting Fee | $4,125.00 |
| Travel and Lodging | $3,343.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $40,390.55 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $31,653.91 | 2019-2025 | General - Therapies, Farapulse, Watchman |
| Medtronic USA, INC. | $7,349.64 | 2019-2020 | |
| Abbott Laboratories | $1,363.57 | 2020-2025 | Perclose Prostyle, Aveir, Perclose Proglide |
| Medtronic, INC. | $578.12 | 2023-2025 | Affera Mapping System, Diamondtemp Bidirectional Ablation Catheter, Cobalt Dr Mri Surescan |
| Cardiva Medical, INC. | $547.14 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Biosense Webster, INC. | $416.57 | 2024-2025 | Carto 3, Nuvision Ice Catheter, Soundstar |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $344.17 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $259.94 | 2021-2022 | |
| Merit Medical Systems INC | $250.00 | 2024 | |
| Abiomed | $161.11 | 2022 | |
| Philips North America LLC | $153.31 | 2023-2025 | (9520) Igt Devices Undivided, Holter |
| Pfizer INC. | $150.35 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $123.31 | 2021 | |
| Novartis Pharmaceuticals Corporation | $113.15 | 2019-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.73 | 2021-2025 | |
| Atricure, INC. | $77.78 | 2023-2024 | |
| Bardy Diagnostics, INC. | $64.28 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $61.72 | 2022-2024 | Onpattro |
| Kestra Medical Technology Services, INC. | $56.66 | 2023-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $40.75 | 2020-2024 | Opsumit, Uptravi |
| Novo Nordisk INC | $34.84 | 2025 | Wegovy |
| Scpharmaceuticals INC. | $29.31 | 2023 | |
| Vital Connect, INC | $27.21 | 2025 | Vitalpatch Rtm |
| Angiodynamics, INC. | $22.41 | 2023 | Alphavac |
| Kiniksa Pharmaceuticals, LTD. | $20.79 | 2023 | Arcalyst |
| Baxter Healthcare | $19.07 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $16.39 | 2025 | Repatha |
| Cordis US Corp. | $15.68 | 2025 | Mynx Control Venous |
| Bard Access Systems, INC. | $15.46 | 2019 | |
| Inspire Medical Systems, INC. | $14.88 | 2023 | Inspire |
| Elutia, INC. | $14.15 | 2021 | |
| Itamar Medical INC | $11.98 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Joyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.